Rxcurve
HCPCS J3376 · per 10 MG

Inj vancomycin (hikma) 10mg

Products billed under this code include Vancomycin HCl.

Payment limit per 10 MG, by effective quarter, 1Q26 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J3376

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Vancomycin HCl Hikma Pharmaceuticals USA Inc. 00143-9161-10 500 $8.00
Vancomycin HCl Hikma Pharmaceuticals USA Inc. 00143-9161-25 1250 $20.00
Vancomycin HCl Hikma Pharmaceuticals USA Inc. 00143-9162-10 1000 $16.00
Vancomycin HCl Hikma Pharmaceuticals USA Inc. 00143-9163-01 500 $8.00
Vancomycin HCl Hikma Pharmaceuticals USA Inc. 00143-9164-01 1000 $16.00

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $0.016 −$0.001 10 MG Inj vancomycin (hikma) 10mg v1, posted September 17, 2026
3Q26 $0.017 +$0.003 10 MG Inj vancomycin (hikma) 10mg v1, posted September 15, 2026
2Q26 $0.014 −$0.005 10 MG Inj vancomycin (hikma) 10mg v1, posted September 15, 2026
1Q26 $0.019 – 10 MG Inj vancomycin (hikma) 10mg v1, posted September 15, 2026

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files